Continuing Education Credits
ACCREDITED CONTINUING EDUCATION
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and The Hospital and Healthsystem Association of Pennsylvania. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 4.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation for Pharmacists
This application-based activity is approved for a maximum of 4.0 contact hours of continuing pharmacy education credit.
Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for a maximum of 4.0 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
As a Jointly Accredited Organization, AXIS Medical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AXIS Medical Education maintains responsibility for this course. Social workers completing this course receive a maximum of 4.0 continuing education credits.
AXIS Contact Information
For information about the accreditation of this program please contact AXIS at info@axismeded.org.
Disclosure of Conflicts of Interest
AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is t producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity.
AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.
The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:
|
Name of Faculty or Presenter
|
Reported Financial Relationship
|
|
Richard Bottner, DHA, PA-C
|
Nothing to disclose
|
|
Christopher Moriates, MD
|
Nothing to disclose
|
|
Hemali Patel, MD
|
Nothing to disclose
|
|
Evan Solice
|
Nothing to disclose
|
|
David Greenspan, MD
|
Nothing to disclose
|
|
Brooke M. Feldman, MSW
|
Nothing to disclose
|
|
John Hartnett
|
Nothing to disclose
|
|
Rebecca Moyer, AA, CRSS, CRS
|
Nothing to disclose
|
|
Tara M. Tawil, MD
|
Nothing to disclose
|
|
Amanda Dodd
|
Nothing to disclose
|
|
Julie D’Alo, MD
|
Nothing to disclose
|
|
Jane M. Liebschutz, MD, MPH, FACP
|
Nothing to disclose
|
|
Leonard Kamen, DO
|
Advisory board and Speaker’s bureau: Indivior and BDSI Pharmaceutical Co.
|
|
Mike S. Krafick
|
Nothing to disclose
|
|
Kory London, MD, FACEP
|
Nothing to disclose
|
|
Jeffrey Gillingham, MPH
|
Nothing to disclose
|
|
Madalene Zale, MPH
|
Nothing to disclose
|
|
Charles Barbera, MD
|
Nothing to disclose
|
|
Lee Radosh, MD, FAAFP
|
Nothing to disclose
|
|
Elizabeth (Libby) Jones
|
Nothing to disclose
|
|
Jenna Bluestein, MPP
|
Nothing to disclose
|
|
Jennifer Jordan
|
Nothing to disclose
|
|
Mitchell Crawford, DO
|
Nothing to disclose
|
|
Michael Lynch, MD
|
Nothing to disclose
|
|
Jared Shinabery, MPH
|
Nothing to disclose
|
|
Jeanmarie Perrone, MD, FACMT
|
Nothing to disclose
|
The directors, planners, managers and reviewers reported the following financial relationships they have with any ineligible company of any amount during the past 24 months:
|
Name of Planner/Manager/Reviewer
|
Reported Financial Relationship
|
|
Ronald Viggiani, MD
|
Nothing to disclose
|
|
Dee Morgillo, MEd, MT(ASCP), CHCP
|
Nothing to disclose
|
|
Holly M. Hampe, DSc., RN, MHA, MRM, CPHQ
|
Nothing to disclose
|
|
Pamela Braun
|
Nothing to disclose
|
|
Jennifer Jordan
|
Nothing to disclose
|
|
Daneen Schroder
|
Nothing to disclose
|
|
Elizabeth (Liz) Owens, MS
|
Nothing to disclose
|
|
Kaynaat Syed, MHA
|
Nothing to disclose
|
|
Marty Kenyon
|
Nothing to disclose
|
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Requirements for credit:
- Attend/participate in the educational activity and review all course materials.
- Complete the CE Attestation form online by 11:59 pm ET July 31, 2021. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
- Upon successful completion of the online form, your statement of completion will be presented to you to print. Pharmacists – your record will be automatically loaded to CPEMonitor.